We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TELL
6251
DELISTED
Tellurian Inc.
TELL
$4K ﹤0.01%
+300
New +$3.87K
RETA
6252
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4K ﹤0.01%
178
-803
-82% -$19.8K
HIL
6253
DELISTED
Hill International, Inc. Common Stock
HIL
$4K ﹤0.01%
896
+287
+47% +$1.43K
AMPE
6254
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$4K ﹤0.01%
16
+13
+433% +$3.49K
SREV
6255
DELISTED
ServiceSource International, Inc.
SREV
$4K ﹤0.01%
1,137
-1,129
-50% -$5.35K
ADMS
6256
DELISTED
Adamas Pharmaceuticals
ADMS
$4K ﹤0.01%
237
-3,721
-94% -$63.4K
SQBG
6257
DELISTED
Sequential Brands Group, Inc.
SQBG
$4K ﹤0.01%
25
+1
+4% +$164
LN
6258
DELISTED
LINE Corporation
LN
$4K ﹤0.01%
100
VSI
6259
PUT
DELISTED
Vitamin Shoppe Inc.
VSI
$4K ﹤0.01%
+200
New +$4.27K
OLBK
6260
DELISTED
Old Line Bancshares, Inc.
OLBK
$4K ﹤0.01%
139
-19
-12% -$527
PES
6261
CALL
DELISTED
Pioneer Energy Services Corp.
PES
$4K ﹤0.01%
1,000
-2,300
-70% -$12.8K
ARRY
6262
CALL
DELISTED
Array Biopharma Inc
ARRY
$4K ﹤0.01%
+400
New +$4.26K
ESIO
6263
DELISTED
Electro Scientific Industries
ESIO
$4K ﹤0.01%
627
-1,379
-69% -$9.07K
IMPV
6264
CALL
DELISTED
Imperva, Inc.
IMPV
$4K ﹤0.01%
+100
New +$4.17K
EOCC
6265
DELISTED
Enel Generacion Chile S.A.
EOCC
$4K ﹤0.01%
204
-40
-16% -$818
QCP
6266
CALL
DELISTED
Quality Care Properties, Inc.
QCP
$4K ﹤0.01%
220
-1,360
-86% -$24.2K
KND
6267
CALL
DELISTED
Kindred Healthcare
KND
$4K ﹤0.01%
500
-10,800
-96% -$84.5K
XBKS
6268
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$4K ﹤0.01%
153
-59
-28% -$1.57K
WFBI
6269
DELISTED
WashingtonFirst Bankshares Inc
WFBI
$4K ﹤0.01%
139
+39
+39% +$1.09K
NUTR
6270
DELISTED
Nutraceutical International Co
NUTR
$4K ﹤0.01%
143
-432
-75% -$14.6K
ADPT
6271
CALL
DELISTED
Adeptus Health Inc
ADPT
$4K ﹤0.01%
2,000
+1,700
+567% +$9.54K
PHIIK
6272
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$4K ﹤0.01%
309
+55
+22% +$834
MCF
6273
DELISTED
Contango Oil & Gas Co.
MCF
$4K ﹤0.01%
514
+433
+535% +$3.4K
XTLY
6274
DELISTED
Xactly Corporation
XTLY
$4K ﹤0.01%
386
-3,972
-91% -$47.2K
AKO.B icon
6275
Embotelladora Andina Series B
AKO.B
$4.72B
$3K ﹤0.01%
124
-4,876
-98% -$112K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.